Introduction
Aging results from decrease in rejuvenation/regeneration potential of several vital organs and tissues. Since tissue regeneration depends on a proper function of stem cells, multipotent stem/primitive cells become a major focus of interest in regenerative medicine (Asahara et al., 1999; Brazelton et al., 2000; Corti et al., 2004; Dawn et al., 2005; Ratajczak et al., 2007b) . Aging processes could be explained by (i) age-related stem cell dysfunction, (ii) accumulation of mutations in stem cell pool over a life-span and (iii) shortening of the telomeres as result of decrease in telomerase activity. Recently, based on our data showing a presence of very small embryonic-like (VSEL) stem cells in murine BM (Kucia et al., 2006a; Zuba-Surma et al., 2007a) and human cord blood (CB) as well as in several solid organs (Kucia et al., 2007d) , we proposed a hypothesis that these cells are deposited during embryonic development in adult tissues as a mobile pool of circulating pluripotent stem cells (PSC) and that the number of these cells decreases with the age . Thus, aging could be at least partially explained by aging-dependent exhaustion of pool of circulating PSC in adult tissues.
We hypothesize that VSELs are a dormant quiescent population of small CXCR4 + SSEA + Oct-4 + Nanog + PSC that (i) are descendants of epiblast-derived stem cells (EPSC) including some primordial germ cells (PGC) (ii) are deposited during development and reside in BM and other adult tissues, (iii) after being mobilized from BM into peripheral blood, these cells may participate in turnover of other tissue specific (monopotent) stem cells that are located in peripheral niches, (iv) when mobilized may also play a role in tissue/organ regeneration, as seen during stress situations or organ injuries, and (v) number of these cells in the adult tissues decreases with the age (Kucia et al., 2006a; Ratajczak et al., 2007a) . On the other hand, we hypothesize that since there is ''a thin red line'' between regeneration and tumor formation, it is likely that this population of very primitive stem cells may give rise to some types of cancer (e.g., pediatric sarcomas, teratomas, germinal tumors) when exposed to mutagenic environment (Buzzeo et al., 2007; Kucia et al., 2007d; Li et al., 2006; Liu et al., 2006; Oakley and Van Zant, 2007) . In this review we will describe the most important features of VSELs and discuss a potential role of these cells in rejuvenation/ regeneration of tissues in steady-state conditions as well as during emergencies related to tissue damage. We will also present an evidence that the number of VSELs and their ability to form spheres, composed of primitive stem cells that possess ability to Recently our group identified in murine bone marrow (BM) and human cord blood (CB), a rare population of very small embryonic-like (VSEL) stem cells. We hypothesize that these cells are deposited during embryonic development in BM as a mobile pool of circulating pluripotent stem cells (PSC) that play a pivotal role in postnatal tissue turnover both of non-hematopoietic and hematopoietic tissues. During in vitro co-cultures with murine myoblastic C2C12 cells, VSELs form spheres that contain primitive stem cells. Cells isolated from these spheres may give rise to cells from all three germ layers when plated in tissue specific media. The number of murine VSELs and their ability to form spheres decreases with the age and is reduced in short-living murine strains. Thus, developmental deposition of VSELs in adult tissues may potentially play an underappreciated role in regulating the rejuvenation of senescent organs. We envision that the regenerative potential of these cells could be harnessed to decelerate aging processes.
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differentiate into cells from all three germ layers, decreases in mice with the age and is reduced in short-living murine strains.
Bone marrow as a home of versatile stem cells
Recent evidence indicates that BM contains a heterogeneous population of non-hematopoietic stem cells in addition to well described hematopoietic stem cells (HSC) (Kucia et al., 2005; Orkin and Zon, 2002) . The cells of non-hematopoietic compartment of BM display several features of pluripotent stem cells (PSC) and have been variously described in the literature as (i) mesenchymal stem cells (MSC) (Anjos-Afonso and Bonnet, 2007; Friedenstein et al., 1966; Peister et al., 2004; Prockop, 1997) , (ii) multipotent adult progenitor cells (MAPC) (Jiang et al., 2002) , (iii) marrowisolated adult multilineage inducible (MIAMI) cells (D'Ippolito et al., 2004) , very small embryonic-like (VSEL) stem cells Kucia et al., 2006a) or (iv) multipotent adult stem cells (MASC) (Beltrami et al., 2007) . Unexpectedly, BM was recently also identified as a potential source of precursors of germ cells (oocytes and spermatogonial cells) (Johnson et al., 2005; Nayernia et al., 2006) . We envision the possibility that in some cases similar or overlapping populations of primitive stem cells in the BM were detected using different experimental strategies and hence were assigned different names.
All the BM-derived non-hematopoietic stem cells listed above (MAPC, MIAMI, VSEL and MASC) have been demonstrated to be able in vitro cultures to differentiate into cells from all three germ layers. However, despite several attempts made so far, there is no convincing data proving that any type of these cells may contribute to the development of multiple organs and tissues when injected into the developing blastocyst. Thus, this important criterion for in vivo pluripotentiality is still missed for stem cells isolated from adult tissues. The potential explanation for this ''deficiency'' will be discussed latter on in this paper.
Generally, it has been hypothesized that the potential presence of PSC in the BM was a result of the ''developmental migration'' of stem cells during ontogenesis and that these cells found a permissive microenvironment in bone marrow tissue (Kucia et al., 2007d; Ratajczak et al., 2007a) . To support this hypothesis, we established that VSELs express CXCR4 (achemokine G ai protein-coupled seven transmembrane span receptor) and c-met (tyrosine kinase receptor) which are responsible for the robust response of VSELs to the cognate ligands of these receptors-stromal derived factor-1 (SDF-1) and hepatocyte growth factor/scatter factor (HGF/SF), respectively (Ratajczak et al., 2006) . Since SDF-1 and HGF/SF are secreted by BM microenvironment, both SDF-1-CXCR4 and HGF/SF-c-met axes may play a pivotal role in accumulation of VSELs in BM tissue (Ratajczak et al., 2006) . On the other hand, VSELs residing in the BM could be released/mobilized into circulation if needed, such as during pharmacological G-CSF-induced mobilization or during stress-related processes following tissue/organ injury (Kucia et al., 2004; Kucia et al., 2006b ).
Isolation of very small embryonic-like stem cells
Very small embryonic-like stem cells have been recently isolated and characterized by our team. These cells were detected in adult bone marrow and other organs as the first adult tissuederived primitive population with embryonic-like features that have been purified at the single cell level (Kucia et al., 2006a (Kucia et al., , 2007d Zuba-Surma et al., 2007a) .
VSELs were isolated by multiparameter FACS sorting as a population of rare ($0.01% of BM MNC) Sca-1 + lin À CD45 À cells (Kucia et al., 2006a) . They express (as determined by RQ-PCR and immunhistochemistry) markers of pluripotent stem cells such as SSEA-1, Oct-4, Nanog, Rex-1 and Rif-1 telomerase protein. Direct electron microscopical analysis revealed that these cells display several features typical for embryonic stem cells such as (i) a small size ($3.5 mm in diameter), (ii) a large nucleus surrounded by a narrow rim of cytoplasm, and (iii) open-type chromatin (euchromatin) (Kucia et al., 2006a) . Analysis employing ImageStream system ( Fig. 1) confirmed a very small size of VSELs as well as other features related to their primitivity such as high nuclear to cytoplasmic ratio . We found that VSELs may be released from BM and circulate in blood during tissue/ organ injury (e.g., heart infarct, stroke, skeletal muscle and liver damage). This suggests that they may play an underappreciated role in tissue/organ regeneration in pathological emergency situations (Kucia et al., 2004 (Kucia et al., , 2006b .
VSELs are smaller than erythrocytes and larger than platelets (Kucia et al., 2007d) . They can be distinguished from large platelets not only based on different surface markers, but also because of the content of nuclei (Fig. 1) . Interestingly, despite their small size, VSELs posses diploid number of chromosomes and contain numerous mitochondria. They do not express MHC molecules of class I and II as well as CD90, CD105 and CD29 antigens. Thus, for the first time a sorting procedure allowing purification of distinct population of adult BM-derived very primitive embryonic-like stem cells have been developed and morphology as well as surface markers of these rare cells were described at the single cell level (Kucia et al., 2006a; Zuba-Surma et al., 2007a) .
We found that $5-10% of purified VSELs co-cultured over a C2C12 murine sarcoma cell feeder layer are able to form spheres that resemble embryoid bodies. Cells from these VSEL-derived spheres (VSEL-DS) are composed of immature cells with large nuclei containing euchromatin, and similarly to purified VSELs, exhibit CXCR4 + SSEA-1 + Oct-4 + phenotype. Furthermore, VSEL-DS, after re-plating over C2C12 cells, may again (up to 5-7 passages) grow new spheres or, if plated into cultures promoting tissue differentiation, give rise into cells from all three germ-cell layers (Kucia et al., 2006a) . The observation that VSELs isolated from GFP + mice grew GFP + VSEL-DS showing a diploid content of DNA, confirms the VSELs' origin of VSEL-DS as well as excludes their development from the supportive C2C12 cell line and excludes the possibility of cell fusion (Kucia et al., 2006a) . Similar spheres were also formed by VSELs isolated from murine fetal liver, spleen and thymus. Since VSELs express several markers of primordial germ cells including fetal-type alkaline phosphatase, Oct-4, SSEA-1, CXCR4, Mvh, Stella, Fragilis, Nobox, and Hdac6, they could be closely related to the population of epiblast-derived PGC (Kucia et al., 2006a; Ratajczak et al., 2007a) . VSELs, as mentioned above, are also highly mobile and respond robustly to SDF-1 gradient, adhere to fibronectin and fibrinogen, and may interact with BM-derived stromal fibroblasts. Confocal microscopy and time laps studies revealed that these cells attach rapidly to, migrate beneath and undergo emperipolesis in marrow-derived fibroblasts (Kucia et al., 2006a . Since fibroblasts secrete SDF-1 and other chemoatractants they may create a homing environment for small CXCR4 + VSELs. These robust interactions of VSELs with BM-derived fibroblasts do have an important implication, namely that isolated BM stromal cells may be contaminated by these tiny cells from the beginning when isolated and cultured in vitro. Importantly, this observation may explain the unexpected ''plasticity'' of marrowderived fibroblastic cells (e.g., MSC or MAPC).
There is also another potential explanation why VSELs as described above may hide in fibroblastic cells. Since VSELs do not express MHC-I molecules and could become a potential target for elimination by NK cells, they may evoke attack from NK cells while hiding inside of fibroblasts. Similar mechanism called entosis was recently described for cancer cells that in certain circumstances may lead to promoting survival of cancer cells that hide inside other cells (Overholtzer et al., 2007) .
Finally, recently a very similar population of cells that show similar morphology and markers to murine BM-derived VSELs was purified from human cord blood (CB) . The major antigenic phenotype of these human CB-derived cells has been established as CD133 Kucia et al., 2007a ). In conclusion it is anticipated that VSELs isolated from BM as well as CB could become an important source of pluripotent stem cells for regeneration. At this point, however, it is not clear whether VSEL contribute to the blastocyst development.
Reprogramming of somatic cells-inducible pluripotent stem cells (iPSC) versus VSELs
Recent evidence shows that an appropriate ''cocktail'' of expression vectors encoding four transcription factors such as Oct-4, Sox2, Myc and Klf4 can reprogram murine fibroblasts to an embryonic status. Such manipulation reawakens silenced segments in the genome of already differentiated cell and reestablishes pluripotency of its nucleus (Meissner et al., 2007; Takahashi et al., 2007) . This interesting approach was already confirmed by three independent laboratories. Cells from the clones of cells developmentally reverted by this strategy contribute to blastocyst development not only in standard assay but also give rise to the development of a whole embryo during tetraploid complementation assay. Cells generated by this strategy, however have the potential to develop teratomas if injected into syngeneic mice. Thus, the potential clinical application of this strategy to obtain iPSC by ''debugging cellular reprogramming'' by multiple transduced genes requires further validation.
If we compare reprogrammed somatic cells (e.g., fibroblasts) and VSELs, important analogies and differences occur. On one hand, fibroblasts to be transduced with the cocktail of transcription factors, in contrast to VSELs possess a proper somatic imprint on maternal and paternal chromosomes. On the other hand, however, VSELs, which our preliminary data already suggests erased somatic imprint, have constitutive expression of all these genes that have to be first over-expressed in fibroblasts (e.g., Oct-4, Sox-2, Myc and Klf4). Therefore, one of the potential strategies to obtain stem cells that will display all the features of PSC (including potential for blastocyst complementation) would be ''debugging cellular reprogramming'' by transducing cells by multiple transcription factors (Oct-4, Sox-2, Myc and Klf4) (1st scenario). The other one would rely on the re-establishment of the proper somatic imprint in VSELs (2nd scenario). Our team is currently focused on this second possibility-re-establishment of a proper somatic imprint in VSELs.
Very small cells in adult tissues
Data obtained in our laboratory clearly demonstrate the presence of small primitive nucleated cells in adult BM and other tissues that are slightly larger than blood platelets yet smaller than erythrocytes (Fig. 1) . Employing ImageStream system we could visualize the VSELs and compare them directly with erythrocytes and platelets. ImageStream is a novel system which similarly to flow cytometry analyzes cells in suspension but also takes the images of acquired objects ,c, 2008 .
Generally, the presence of cells possessing similar small size (<5 mm) in adult murine tissues has been postulated recently by Vacanti et al. (2001) . These cells were introduced as ''spore-like stem cells''. Unfortunately the isolation strategy of spore-like stem cells was not clearly described by the authors in the original paper and thus it was not specified how these cells were isolated from adult tissues (Vacanti et al., 2001 ). In contrast, by employing FACSbased phenotypic analysis of single cell suspensions prepared from murine brain, blood, and intestinal epithelium, Howell et al. also recently found in the subventricular zone of the murine brain (Scheffler et al., 2005) . Finally, Hung and colleagues described a population of very small cells residing in human BM during isolation of mesenchymal stem cells (MSCs) on double layer culture plates containing 3-mm pores employed to sieve out the relatively large mesenchymal stem cells (Hung et al., 2002) .
VSEL number and function in aging
Employing flow cytometry, we evaluated the content of VSELs among small BM-derived Sca-1 + Lin À nucleated cells isolated from mice at different ages (2 months-3 years) (Fig. 2) . Cells that display VSEL phenotype were also identified in several other adult organs (Fig. 3) . However, we noticed that the number of these cells (Sca-1 + Lin À CD45 À ) in BM from C57BL/6 mice gradually decreases over time from 0.052 AE 0.018% to 0.003 AE 0.002% between age of 2-months and 3-years, respectively (Fig. 2 panel D) . More importantly, not only a number of these cells in adult organs decrease with the age but also their ability to form spheres containing primitive stem cells (VSEL-DS) declaims with time (Fig. 4) . This age-dependent content of VSELs in BM may explain why the regeneration processes are more efficient in younger individuals, when compared to older organisms.
Moreover, we have also established the differences in the content of VSELs among BM-derived nucleated cells isolated from long-and short-lived murine strains. We reported that the number of these cells is much higher in BM of long-lived (e.g., C57BL/6) as compared to short-lived (DBA/2J) mice (Kucia et al., 2006a) . In our opinion, it would be interesting to identify genes that are responsible for tissue distribution/expansion of these cells as they could be involved in controlling the life span of mammals.
However, there are more scientific challenges coming out from recent VSELs' studies. Based on our animal data it would be interesting to study whether the number of VSELs depends also on human age. It would be also important to evaluate if there are some differences in VSELs number in BM and other tissues as function of senescence between members of long-and short-living families.
Developmental origin of VSELs
An important question to be answered is the developmental origin of VSEL stem cells. We hypothesize that these cells are specified early during development at the stage of so-called ''cylinder embryo'' in the primitive ectoderm (epiblast). We also envision that VSELs are direct descendants from the germ lineage. From developmental point of view, this is the most important cell lineage in the body (Drenos and Kirkwood, 2005; Kucia et al., 2007b; Ratajczak et al., 2007a; Weismann, 1885; Zwaka and Thomson, 2005) . The significance of this statement will be justified below.
It has been widely accepted that from the developmental and evolutionary point of view, the main goal of the multicellular organism is to pass genes to the next generations. This process is orchestrated by the highly developed interactions between germ and somatic cell lines (Weismann, 1885) . The germ line carries the genome (nuclear and mitochondrial DNA) from one generation to the next generation being the only cell lineage which preserve true developmental totipotency (Donovan, 1998; Zwaka and Thomson, 2005) . In this context, we can envision that all somatic cells are descendants from the germ line and help germ cells to accomplish this mission effectively.
To support this concept, we can look at the zygote, derived directly during fertilization from the fusion of two germ cells (female oocyte and male sperm), as the most primitive totipotent germ stem cell capable to form both embryo and extra-embryonic tissues (placenta). During fertilization the haploid number of chromosomes derived from an oocyte is combined with haploid number of chromosomes of a male sperm, and thus the zygote could be envisioned as a mother cell to the germ lineage which ''down the road'' will give rise to (i) more differentiated cells from the germ lineage-gametes (responsible for the transfer of genome to the next generation) and (ii) other somatic lineages that provide the soma to fulfill this mission. These somatic cells develop from the germ lineage during embryogenesis. In this context, the body/ soma becomes a ''vehicle'' protecting the germ lineage and allowing to pass the genomic information to the progeny .
The germ potential of the zygote is retained in the (i) first blastomers, (ii) cells of developing morula and (iii) cells from the inner cell mass (ICM) of a blastocyst. However, at this time of development, some level of specification already occurs and the trophoectoderm ''buds out'' from the germ line. Trophoectoderm is responsible for formation of the placenta and the remaining part of the blastocyst, while ICM will give rise to the embryo including epiblast. Epiblast stem cells (EPSC) have been also demonstrated to preserve pluripotency as well as retain germ lineage potential (Matsui et al., 1992; Shamblott et al., 1998; Yamazaki et al., 2003) . EPSC express following antigens related to their pluripotent stage: SSEA-1 (mice), SSEA-3/4 (human), Oct-4 and Nanog. They give rise to all three germ layers, ecto-, meso-and endoderm including primordial germ cells (PGC). Thus, the epiblast, through the process of gastrulation, is the source of all stem cells for all the germ layers. The stem cells in these layers give rise to all of the tissues and organs in the embryo. Thus, EPSC could be envisioned as a founder population of PSC for multipotent stem cells of ecto-, endo-or mesoderm that subsequently give rise to unipotent stem cells which develop several somatic cell lineages in the next stages of embryonic development Rossant, 2007; Yamanaka et al., 2006) . These Oct-4 + EPSC may survive in the tissues and organs into adulthood as a founder population of stem cells (Fig. 3) . Furthermore, there is also evidence that also some of the epiblast-derived PGC may go astray during their migration through the embryo to the genital ridges and seed to peripheral tissues (Upadhyay and Zamboni, 1982) .
Status of somatic imprint-functional implications for potential PSC in adult organs/tissues?
The most valuable assay to demonstrate that a given stem cell is truly pluripotent is an assay based on the developmental complementation of the blastocyst. In this assay, candidate PSC is injected into developing blastocyst and subsequently the embryo or the neonatal mouse is examined if the potential candidate cell contributed to development of organs and tissues belonging to all three germ layers Jaenisch, 2003, 2006; Prelle et al., 2002) . In fact this had been not shown yet in a reproducible manner for any type of stem cell isolated from the adult tissues.
We hypothesize that the problem with providing such evidence could be explained by the possibility that all PSC that reside in adult tissues erase ''somatic imprint'' that means different methylation of some maternally and paternally inherited genes (e.g., H19, Igf-2, Igf-2R, Snrpn) (Lee et al., 2002; Mann, 2001) . For example, Igf-2 is expressed from paternal and H19 from maternal chromosome. The erasure of somatic imprint on these genes by demethylation process protects developing organism from parthenogenesis and teratoma formation. However, on the other hand, prevents the contribution of surviving into adulthood PSC to complete blastocyst development (Lee et al., 2002; Mann, 2001) .
The phenomenon of erasure of the somatic imprint was studied extensively in a case of epiblast derived PGC (Lee et al., 2002; Mann, 2001) . Accordingly, shortly before the epiblast is about to give rise to all three germ layers (ectoderm, mesoderm and endoderm), the first morphologically identifiable precursors of primordial germ cells (PGC) in mice become specified $6.0-6.5 days post-conception (dpc) in the proximal part of the epiblast as the first population of stem cells in the embryo at the beginning of gastrulation (McLaren, 1992 (McLaren, , 2003 . PGC in mice subsequently move for a short period of time first to the basis of alantois, which is located in the extraembryonic mesoderm and then migrate into the embryo proper towards the genital ridges-where finally they will undergo developmental differentiation to oocytes or sperm, respectively (Molyneaux and Wylie, 2004) . Interestingly, the migrating PGC, in contrast to EPSC, loose their pluripotency. Namely, migrating PGC, freshly isolated from embryo, proliferate in vitro only for a few days, and then disappear either because they differentiate or die (De Felici and McLaren, 1983) . Furthermore, while the nuclei of even terminally differentiated somatic cells (e.g., fibroblasts, lymphocytes) can be successfully used as donors for nuclear transfer and may give rise to the clonote, nuclei from PGC at 11.5 dpc and later are incompetent to support full-term development of clonote (Yamazaki et al., 2003) . This is somehow intriguing, taking into consideration that PGC are the population of stem cells that carries ''developmental totipotency'' for oocytes and sperm.
However, on the other hand, when PGC are cultured over murine embryonic fibroblasts and exposed ex vivo to following growth factors: kit ligand (KL), leukemia inhibitory factor (LIF) and basic fibroblast growth factor (FGF-2), they continue proliferation and form large colonies of embryonic germ cells (EG) which similarly to embryonic stem cells (ESC) can be expanded indefinitely (Matsui et al., 1992; Shamblott et al., 1998; Turnpenny et al., 2003) . Such EG have been derived from pre-and postmigratory, as well as from migratory PGC in both mice and humans and were described as cells preserving pluripotency (Matsui et al., 1992; Shamblott et al., 1998) . Namely, EG in contrast to PGC, fully contribute to all three germ layers in blastocyst complementation assay giving rise to all somatic lineages and germ cells of the developing embryo.
To explain this phenomenon at the molecular level, we need to noticed that PGC display a proper somatic imprint (paternal and maternal pattern of methylation) of H19, Igf-2, Igf-2R, Snrpn genes until 9.5 dpc-that is crucial to maintain their pluripotency (Mann, 2001; Yamazaki et al., 2003) . The somatic imprint, however, is erased in PGC by demethylation while these cells migrate towards the genital ridges $10.5 dpc (Lee et al., 2002) . The erasing of the methylation (imprint) of H19, Igf-2, Igf-2R, and Snrpn in early PGC could make these cells resistant to parthenogenesis or formation of teratomas, but on the other hand shuts down PGC developmental pluripotency (Macchiarini and Ostertag, 2004; Oosterhuis and Looijenga, 2005) . A proper somatic imprint is subsequently again re-established in developing gonads in haploid gametes (sperm and oocytes), so that a fertilized egg (zygote) expresses a developmentally proper somatic imprint of these crucial genes.
We hypothesize that an analogical mechanism of somatic imprint erasure takes place during development, not only in PGC but also in other EPSC-derived PSC that are deposited in the developing organs, e.g., VSELs (Fig. 3) . Due to the erasure of somatic imprint, deposited in adult tissues PSC loose their ability to complete blastocyst development. However, the fact that PGCderived EG cells regain their pluripotentiality, demonstrates that the erasure of somatic imprint is reversible. It is also possible that similarly as PGC, also other PSC residing in adult tissues may regain a proper somatic imprint under certain circumstances (e.g., tissue/ organ injury) . This may occur through epigenetic changes. It is no doubt that the identification of genes/ proteins involved in this phenomenon will be crucial for manipulating pluripotentiality of somatic stem cells.
The potential role of VSELs in pathology
In parallel, evidence has accumulated that BM-derived stem cells may play an undesirable role in the development of some pathologies. We hypothesize, that if VSELs are mobilized at the wrong time and home to the wrong place (e.g., into areas of chronic inflammation) they may exert unwanted effects (Reya et al., 2001; Virchow, 1855) . For example, BM-derived stem/progenitor cells have been implicated in the pathogenesis of lung fibrosis, ocular pterygia and diabetic neuropathy (Hasegawa et al., 2006; Hashimoto et al., 2004; Song et al., 2005) .
It has been also found that BM-derived stem cells may also contribute to the development of some non-hematopoietic tumors. This possibility was recently demonstrated in a model of murine stomach cancer caused by a chronic Helicobacter pylori (HP) infection (Houghton et al., 2004) . The potential role of VSELs in this phenomenon requires further studies. In addition, mounting evidence also suggests that BM may be a source of endothelial progenitor cells and stromal cells for developing cancer tissue (Dome et al., 2006; Tolar et al., 2007) . Thus, BM-stem cells (e.g., VSELs?) may in addition in different ways contribute to both initiation and expansion of the growing tumor.
Conclusions
Data obtained in our laboratory indicate that VSELs could potentially provide a real therapeutic alternative to the controversial use of human ES cells and therapeutic cloning. Hence, while the ethical debate on the application of ES cells in therapy continues, the potential of VSELs is ripe for exploration. Further studies are also required on a role of VSELs in aging. Would it be possible to expand life span of aging mice by transplantation of VSELs isolated from young littermates? Alternatively, it is possible to isolate VSELs from the mouse at young age (by femur aspiration under general anesthesia), store these autologous cells for 1 year, and than inject them into the bone of the same animal. Would this strategy extend life span of this mouse? Thus, researchers working with animal models must determine whether these cells could be efficiently employed in the clinic or whether they are merely developmental remnants found in the BM that cannot be harnessed effectively for regeneration. The coming years will bring important answers to these questions. 
